A MAGE-A3 peptide presented by HLA-DP4 tumor cells to CD4+ cytolytic T lymphocytes

被引：0
|
作者：
Schultz, ES
Lethé, B
Van Snick, J
Chaux, P
Thielemans, K
Corthals, J
Heirman, C
Boon, T
van der Bruggen, P
机构：
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2000年 / 115卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：563 / 563
页数：1
相关论文
共 50 条
  • [21] Scanning the HIV genome for CD4+ T cell epitopes restricted to HLA-DP4, the most prevalent HLA class II molecule
    Cohen, William M.
    Pouvelle-Moratille, Sandra
    Wang, Xiao-Fei
    Farci, Sandrine
    Munier, Gaetan
    Charron, Dominique
    Menez, Andre
    Busson, Marc
    Maillere, Bernard
    [J]. JOURNAL OF IMMUNOLOGY, 2006, 176 (09): : 5401 - 5408
  • [22] Lack of tumor recognition by cytolytic T lymphocyte clones recognizing peptide 195-203 encoded by gene MAGE-A3 and presented by HLA-A24 molecules
    So, Tomoko
    Hanagiri, Takeshi
    Chapiro, Jacques
    Colau, Didier
    Brasseur, Francis
    Yasumoto, Kosei
    Boon, Thierry
    Coulie, Pierre G.
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (02) : 259 - 269
  • [23] The production of a new MAGE-3 peptide presented to cytolytic T lymphocytes by HLA-B40 requires the immunoproteasome
    Schultz, ES
    Chapiro, J
    Lurquin, C
    Claverol, S
    Burlet-Schiltz, O
    Warnier, G
    Russo, V
    Morel, S
    Lévy, F
    Boon, T
    Van den Eynde, BJ
    van der Bruggen, P
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (04): : 391 - 399
  • [24] A MAGE-3 peptide presented by HLA-B44 is also recognized by cytolytic T lymphocytes on HLA-B18
    Bilsborough, J
    Panichelli, C
    Duffour, MT
    Warnier, G
    Lurquin, C
    Schultz, ES
    Thielemans, K
    Corthals, J
    Boon, T
    van der Bruggen, P
    [J]. TISSUE ANTIGENS, 2002, 60 (01): : 16 - 24
  • [25] A MAGE-1 antigenic peptide recognized by human cytolytic T lymphocytes on HLA-A2 tumor cells
    Sabrina Ottaviani
    Yi Zhang
    Thierry Boon
    Pierre van der Bruggen
    [J]. Cancer Immunology, Immunotherapy, 2005, 54 : 1214 - 1220
  • [26] A MAGE-1 antigenic peptide recognized by human cytolytic T lymphocytes on HLA-A2 tumor cells
    Ottaviani, S
    Zhang, Y
    Boon, T
    Van der Bruggen, P
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2005, 54 (12) : 1214 - 1220
  • [27] Function of CD4+ cytolytic T lymphocytes in lung allografts
    Poindexter, NJ
    Sundaresan, RS
    Cooper, JD
    Patterson, GA
    Mohanakumar, T
    [J]. TRANSPLANTATION PROCEEDINGS, 1999, 31 (1-2) : 195 - 196
  • [28] Regulatory function of human CD4+ cytolytic T lymphocytes
    Poindexter, NJ
    Smith, MA
    Haynes, AE
    Mohanakumar, T
    [J]. TRANSPLANT IMMUNOLOGY, 1999, 7 (01) : 45 - 49
  • [29] Selective identification of HLA-DP4 binding T cell epitopes encoded by the MAGE-A gene family
    Wang, Xiao-Fei
    Cohen, William M.
    Castelli, Florence A.
    Almunia, Christine
    Lethe, Bernard
    Pouvelle-Moratille, Sandra
    Munier, Gaetan
    Charron, Dominique
    Menez, Andre
    Zarour, Hassan M.
    van der Bruggen, Pierre
    Busson, Marc
    Maillere, Bernard
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (06) : 807 - 818
  • [30] MAGE-A3 and MAGE-A4 specific CD4+ T cells in head and neck cancer patients: detection of naturally acquired responses and identification of new epitopes
    Cesson, Valerie
    Rivals, Jean-Paul
    Escher, Anette
    Piotet, Elsa
    Thielemans, Kris
    Posevitz, Vilmos
    Dojcinovic, Danijel
    Monnier, Philippe
    Speiser, Daniel
    Bron, Luc
    Romero, Pedro
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (01) : 23 - 35
12345